Related Experiment Video
Updated: Mar 16, 2026
08:32
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
11.0K
Human cytomegalovirus downregulates SLITRK6 expression through IE2
Huanan Liao1, Haruna Sato1, Ryosuke Chiba1
1Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Journal of Neurovirology
|August 18, 2016
Summary
Congenital human cytomegalovirus (HCMV) infection downregulates SLITRK6 gene expression in neural cells. This viral mechanism may contribute to HCMV-induced sensorineural hearing loss and neurological disorders.
Area of Science:
- Neuroscience
- Virology
- Genetics
Background:
- Congenital human cytomegalovirus (HCMV) infection is a leading cause of non-genetic sensorineural hearing loss (SNHL) and other neurological impairments.
- The precise mechanisms underlying HCMV-induced neuropathogenesis remain incompletely understood.
Purpose of the Study:
- To investigate the molecular mechanisms by which HCMV infection affects neural cells.
- To identify specific viral factors involved in HCMV-associated neurological complications, particularly SNHL.
Main Methods:
- Utilized cultured neural cells to model HCMV infection in vitro.
- Quantified the expression levels of the SLITRK6 gene following HCMV infection.
- Investigated the role of HCMV-encoded immediate-early 2 (IE2) proteins and their specific domains in regulating SLITRK6 expression.
Main Results:
- HCMV infection significantly downregulated the expression of SLITRK6 in cultured neural cells.
- HCMV-encoded IE2 proteins were identified as mediators of SLITRK6 downregulation.
- A critical role for the carboxy-terminal region of IE2, specifically amino acid residue Gln548, was demonstrated in this process.
Conclusions:
- The downregulation of SLITRK6 expression by HCMV IE2 proteins is a potential mechanism contributing to HCMV-induced SNHL.
- These findings offer insights into the neuropathogenesis of congenital HCMV infection and potential therapeutic targets.
